EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,421,000 | – | 140,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $34,922,000 | 14.92% |
| RA Capital Management | 2,162,671 | $112,726,000 | 6.05% |
| Opaleye Management Inc. | 305,550 | $9,496,000 | 2.89% |
| EMORY UNIVERSITY | 83,836 | $2,606,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $8,257,000 | 1.15% |
| Cormorant Asset Management, LP | 551,921 | $17,154,000 | 0.98% |
| Redmile Group, LLC | 878,403 | $27,301,000 | 0.77% |
| EAM Investors, LLC | 71,461 | $2,221,000 | 0.54% |
| EAM Global Investors LLC | 40,688 | $1,265,000 | 0.54% |
| Perceptive Advisors | 686,992 | $21,349,000 | 0.49% |